Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair
- Conditions
- Post-Operative PainPelvic Organ Prolapse
- Registration Number
- NCT00695240
- Lead Sponsor
- St. Luke's Hospital, Kansas City, Missouri
- Brief Summary
This prospective randomized controlled study will determine the efficacy of continuous local anesthesia at decreasing pain scores compared to patient controlled analgesia for pelvic organ prolapse procedures including posterior colporrhaphy and sacrospinous ligament fixation.
- Detailed Description
Direct post-operative analgesia can be administered via a direct continuous analgesia pumps providing local anesthetic into a dissected area. To date, no studies have been conducted to evaluate pain control or infection with vaginal placement of catheters for pelvic organ prolapse surgery. To help pelvic surgeons assess the relative benefit of continuous local infusion of topical anesthetic following sacrospinous ligament fixation versus PCA pump, we compared pain scores, narcotic, anti-pruritic and anti-emetic drug usage, and wound complications.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 80
- Female patients greater than 18 years of age
- Undergoing posterior colporrhaphy at Saint Lukes Hospital, Kansas City, MO.
- Patients with chronic pain conditions requiring daily narcotics were excluded
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The primary outcome was a difference in the Wisconsin Brief Pain Inventory and Visual Acuity Score after treatment with the direct continuous analgesia device compared to PCA alone. Each day post-operatively
- Secondary Outcome Measures
Name Time Method Secondary outcome was differences in the amount of narcotics, NSAIDS, antiemetics, time to return of bladder function, and complications between the study groups. Each day post-operatively
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
St. Luke's Hospital
🇺🇸Kansas City, Missouri, United States
St. Luke's Hospital🇺🇸Kansas City, Missouri, United StatesTyler Muffly, MDSub Investigator